Tällä sivulla oleva materiaali on tarkoitettu ensisijaisesti toimittajille, lehdistölle ja medialle.
Napsauta "KYLLÄ" ja siirry Uutishuoneeseen. Jos napsautat "EI", palaat takaisin sivulle mynewsdesk.com.
Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 20 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients.
Through the outstanding knowledge and commitment of our 15,000 employees worldwide, we create innovative new and generic medicines, and new methods of drug discovery and delivery. We share a passion for innovation, as well as compassion for the patients around the world who are in need of our medicines.
Daiichi Sankyo is based in Tokyo and today has 50 billion yen in capital.